Underlying conditions, such as lymphoproliferative diseases, monoclonal gammopathy of undetermined significance, autoimmune disorders, and solid organ tumors have been associated with the production of C1-INH neutralizing autoantibodies, leading to its consumption [2,4]. Here, SERPING1 is linked to autoimmune disease.